Paratex Names Kris Peterson To Board
This article was originally published in Scrip
Paratek Pharmaceuticals, Inc. has appointed Kris Peterson to its board of directors. Peterson has over 30 years' experience and joins Paratek from Valeritas, Inc. where she was CEO. Previously she was company group chair for Johnson & Johnson's biotech sector and during her time at the company, she was also executive vice president, global marketing and pharmaceuticals. Peterson has also held senior leadership positions at Biovail Corporation and Bristol Myers Squibb in marketing, sales and general management.